Activated STAT3 increases RANTES (regulated upon activation, normal T cell expressed and secreted factor) and anti-apoptotic Bcl-2 and Bcl-xL expression levels that contributes to tamoxifen-resistance in breast cancer [97,100,102,103]. This evidence concerns the gene STAT3 and breast cancer.